Management of toxic epidermal necrolysis
- 1 November 2000
- journal article
- review article
- Published by Mark Allen Group in Hospital Medicine
- Vol. 61 (11) , 778-781
- https://doi.org/10.12968/hosp.2000.61.11.1463
Abstract
Toxic epidermal necrolysis and Stevens–Johnson syndrome are rare, life-threatening drug reactions. Widespread epidermal necrosis and mucosal erosions lead to complications similar to those developing after extensive burns. Treatment is supportive. The role of steroids and other potential disease-modifying agents remains to be established by controlled studies.Keywords
This publication has 18 references indexed in Scilit:
- High‐Dose Systemic Corticosteroids Can Arrest Recurrences of Severe Mucocutaneous Erythema MultiformePediatric Dermatology, 2000
- Toxic Epidermal Necrolysis and Stevens-Johnson SyndromeArchives of Dermatology, 2000
- Treatment of Toxic Epidermal Necrolysis with Cyclosporin APublished by Wolters Kluwer Health ,2000
- Plasmapheresis as an adjunct treatment in toxic epidermal necrolysisJournal of the American Academy of Dermatology, 1999
- Pulmonary complications in toxic epidermal necrolysis: a prospective clinical studyIntensive Care Medicine, 1997
- Efficacy of cyclophosphamide in toxic epidermal necrolysisJournal of the American Academy of Dermatology, 1991
- Toxic epidermal necrolysis (Lyell syndrome)Journal of the American Academy of Dermatology, 1990
- Treatment of Toxic Epidermal NecrolysisArchives of Dermatology, 1987
- Improved Burn Center Survival of Patients with Toxic Epidermal Necrolysis Managed without CorticosteroidsAnnals of Surgery, 1986
- Erythema multiforme in children.British Journal of Dermatology, 1976